Saturday, October 17, 2020 9:50:48 PM
See this link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418975
******* Possible meetings for data presentation *******
Oct 21-22
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158923114
November 04, 2020 - November 07, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942181
November 16-17, 2020
https://investorshub.advfn.com/boards/read_msgs.aspx?board_id=11474
December 09-10, 2020
https://parkinsons.neuroconferences.com/
**********************************************************************
Updated Pipeline
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158910506
Biology concepts for Alzheimer’s disease (2/20 update)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158531542
Actigraph will give objective sleep data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158938705
The slide that mentions Actigraphy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158955971
More comments on Actigraphy
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157152758
Sleep - a few of many papers released within the last year:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942413
PubChem reference for 2-73
https://pubchem.ncbi.nlm.nih.gov/compound/Anavex-2-73#section=Chemical-Disease-Co-Occurrences-in-Literature
see also this post on pubchem info:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822687
Effect of Peroxynitrite:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822263
Autism and Mitochondrial Dysfunction:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964035
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964348
TGA requirements have been discussed for years here.
OLE's may be as valuable as a trial for the purpose of Provisional approval.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158539684
ER–mitochondria signaling in Parkinson’s disease (from mapman's link to article post below)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142355746&txt2find=autophagy
PDF of the article cited:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832754/pdf/41419_2017_Article_79.pdf
From "Compiled: MOA and MEDICAL SCIENCE DISCUSSION 09/29/19" at the following link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418911
ALS and gut bacteria linked in “remarkable” new Harvard study (from georjejjl)
https://newatlas.com/science/als-gut-bacteria-microbiome-harvard-study/
https://www.anavex.com/wp-content/uploads/2019/12/CTAD2019_ANAVEX2-73_P84_Microbiota_.pdf
From MS Today and tradeherpete “Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis”:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155546193
Aarsland has been busy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158700775
Biostockclub holds forth :)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158688526
Basic info on PDD from nidan:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158724733
Air pollution particles in young brains linked to Alzheimer's damage
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158774113
Faster drug approval coming world wide:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158796012
Ransomware attack possible reason for delay in PDD trial data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158710802
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158748463
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158797284
The key lies in being able to accelerate the rate of failure.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158828376
August 15, 2020 Media report on Rett Syndrome trial in Australia.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158829938
COGNITION IN PARKINSON'S
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158855354
Anavex 2-73 made with the SCF, supercritical fluid, for increased bioavaliability.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158825826
From JF comm. 10/08/20, w/ interesting PD comments and future---something about news in October:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158790564
Some of the scientific resources that MJFF utilizes, coordinates and makes available...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897015
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897404
Recent AVXL News
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 03/18/2024 11:30:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM